BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36800954)

  • 1. Serum Rcn3 level is a potential diagnostic biomarker for connective tissue disease-associated interstitial lung disease and reflects the severity of pulmonary function.
    Ding F; Yang L; Wang Y; Wang J; Ma Y; Jin J
    BMC Pulm Med; 2023 Feb; 23(1):68. PubMed ID: 36800954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma LTBP2 as a potential biomarker in differential diagnosis of connective tissue disease-associated interstitial lung disease and idiopathic pulmonary fibrosis: a pilot study.
    Zou M; Hu X; Song W; Gao H; Wu C; Zheng W; Cheng Z
    Clin Exp Med; 2023 Dec; 23(8):4809-4816. PubMed ID: 37864077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum S1P level in interstitial lung disease (ILD) is a potential biomarker reflecting the severity of pulmonary function.
    Ding F; Wang Z; Wang J; Ma Y; Jin J
    BMC Pulm Med; 2024 Jun; 24(1):266. PubMed ID: 38835000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between idiopathic interstitial pneumonias (IIPs) and connective tissue disease-related interstitial lung disease (CTD-ILD): A narrative review.
    Enomoto N
    Respir Investig; 2024 May; 62(3):465-480. PubMed ID: 38564878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of exhaled air analysis in discriminating interstitial lung diseases: a pilot study.
    Plantier L; Smolinska A; Fijten R; Flamant M; Dallinga J; Mercadier JJ; Pachen D; d'Ortho MP; van Schooten FJ; Crestani B; Boots AW
    Respir Res; 2022 Jan; 23(1):12. PubMed ID: 35057817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of interleukin-6, total bilirubin, CD3 + CD4 + T cells counts in the acute exacerbation of connective tissue disease-associated interstitial lung disease: a cross-sectional study.
    Ma C; Meng K; Shi S; Zhao T; Chen S; Zhou X; Shu R; Ma M; Tian M; Ding J
    Eur J Med Res; 2023 Sep; 28(1):393. PubMed ID: 37773193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Idiopathic Pulmonary Fibrosis and Prediction of Disease Severity via Machine Learning Analysis of Comprehensive Metabolic Panel and Complete Blood Count Data.
    Mueller AN; Miller HA; Taylor MJ; Suliman SA; Frieboes HB
    Lung; 2024 Apr; 202(2):139-150. PubMed ID: 38376581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening value of lung ultrasound and pleural shear wave elastography in connective tissue disease-related interstitial lung disease: a preliminary study.
    Han S; Ji Z; Liu Y
    Clin Rheumatol; 2024 Jun; 43(6):2117-2123. PubMed ID: 38700662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interstitial Lung Disease: A Review.
    Maher TM
    JAMA; 2024 May; 331(19):1655-1665. PubMed ID: 38648021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil-To-Lymphocyte Ratio and Systemic Immune-Inflammation Index-Biomarkers in Interstitial Lung Disease.
    Ruta VM; Man AM; Alexescu TG; Motoc NS; Tarmure S; Ungur RA; Todea DA; Coste SC; Valean D; Pop MC
    Medicina (Kaunas); 2020 Jul; 56(8):. PubMed ID: 32751302
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease.
    Pugashetti JV; Khanna D; Kazerooni EA; Oldham J
    Immunol Allergy Clin North Am; 2023 May; 43(2):411-433. PubMed ID: 37055096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors for progressive pulmonary fibrosis in connective tissue disease-related interstitial lung disease.
    Kim K; Lee J; Jo YS
    Ther Adv Respir Dis; 2023; 17():17534666231212301. PubMed ID: 37991015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computed Tomography-Based Deep Learning Model for Assessing the Severity of Patients With Connective Tissue Disease-Associated Interstitial Lung Disease.
    Su N; Hou F; Zheng W; Wu Z; E L
    J Comput Assist Tomogr; 2023 Sep-Oct 01; 47(5):738-745. PubMed ID: 37707403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of serum oncomarkers for patients hospitalized with acute exacerbation of interstitial lung disease.
    Ba C; Jiang C; Wang H; Shi X; Jin J; Fang Q
    Ther Adv Respir Dis; 2024; 18():17534666241250332. PubMed ID: 38757948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of connective tissue disease autoantibodies and a novel autoantibody anti-annexin A11 in patients with "idiopathic" interstitial lung disease.
    Tansley SL; McMorrow F; Cotton CV; Adamali H; Barratt SL; Betteridge ZE; Perurena-Prieto J; Gibbons MA; Kular R; Loganathan A; Lamb JA; Lu H; New RP; Pratt D; Rivera-Ortega P; Sayers R; Steward M; Stranks L; Vital E; Spencer LG; McHugh NJ; Cooper RG;
    Clin Immunol; 2024 May; 262():110201. PubMed ID: 38575043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconciling healthcare professional and patient perspectives in the development of disease activity and response criteria in connective tissue disease-related interstitial lung diseases.
    Saketkoo LA; Mittoo S; Frankel S; LeSage D; Sarver C; Phillips K; Strand V; Matteson EL; ;
    J Rheumatol; 2014 Apr; 41(4):792-8. PubMed ID: 24488412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical effect of progressive pulmonary fibrosis on patients with connective tissue disease-associated interstitial lung disease: a single center retrospective cohort study.
    Lee JK; Ahn Y; Noh HN; Lee SM; Yoo B; Lee CK; Kim YG; Hong S; Ahn SM; Kim HC
    Clin Exp Med; 2023 Dec; 23(8):4797-4807. PubMed ID: 37831431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nailfold capillaroscopy findings of interstitial pneumonia with autoimmune features.
    Lee SH; Min HK; Kim SH; Kim YW; Yoo KH; Kim HJ; Kim IA; Kim HR
    Korean J Intern Med; 2023 Nov; 38(6):903-911. PubMed ID: 37488834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interstitial Lung Disease in Connective Tissue Disease: A Common Lesion With Heterogeneous Mechanisms and Treatment Considerations.
    Shao T; Shi X; Yang S; Zhang W; Li X; Shu J; Alqalyoobi S; Zeki AA; Leung PS; Shuai Z
    Front Immunol; 2021; 12():684699. PubMed ID: 34163483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptomic and network analysis identifies shared and unique pathways and immune changes across fibrotic interstitial lung diseases.
    Liu W; Huang K; Yang XZ; Wang P
    Aging (Albany NY); 2024 Feb; 16(4):3200-3230. PubMed ID: 38349858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.